Application of product for detecting GALNT4 gene in preparation of tool for diagnosis and/or prognosis of coronary heart disease
A coronary heart disease and gene technology, applied in the field of genetic diagnosis and biopharmaceuticals, can solve the problems such as myocardial infarction that cannot be accurately predicted and prevented, and many causes of coronary heart disease.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0064] Example 1: Case Collection
[0065] 1. Selected crowd
[0066] From August 2019 to November 2017, patients who were hospitalized in Beijing Friendship Hospital affiliated to Capital Medical University and received coronary angiography were enrolled. A total of 58 patients with coronary heart disease and 55 patients in the control group who were admitted to the hospital during the same period were excluded from the diagnosis of coronary heart disease.
[0067] 2. Testing standards
[0068] The diagnostic criteria for coronary heart disease are left main and three subepicardial coronary arteries (anterior descending, left circumflex, and right coronary arteries) and any segment of their large branches with a diameter stenosis of ≥50%.
[0069] 3. Selection criteria
[0070] (1) Aged between 18-80 years old (including 18 and 80 years old);
[0071] (2) LVEF ≥ 45% confirmed by transthoracic echocardiography;
[0072] (3) Voluntarily accept all inspections required by th...
Embodiment 2
[0082] Example 2: Detection of GALNT4 gene expression in peripheral blood of coronary heart disease and control group
[0083] 1. Collect peripheral blood and extract mRNA
[0084] (1) Take 5ml of fasting peripheral venous blood from each research subject in the morning, and centrifuge to collect blood cells;
[0085] (2) Add Trizol reagent to fully grind cells or tissue until it becomes paste;
[0086] (3) Add 1 / 5 volume of chloroform, shake vigorously up and down and mix for 15s, stand at room temperature for 15min, centrifuge at 12000g for 15min at 4°C;
[0087] (4) Carefully take out the EP tube from the centrifuge, at this time the homogenate is divided into 3 layers, that is, the colorless supernatant is RNA, the white egg layer in the middle and the lower organic phase with color; carefully suck the upper aqueous phase Transfer to another new EP tube, do not aspirate the white intermediate layer;
[0088] (5) Add equal volume of isopropanol to the supernatant, invert u...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


